Founded originally in 1991 by a pediatric cardiac nurse, AMI started first as a Holter monitoring service. AMI has evolved into a boutique ambulatory cardiac monitoring service for patients needing all modalities of diagnostic outpatient arrhythmia monitoring. Our service delivery platform is customized to the needs of our clients, and includes prompt access to clinical and support staff 24 hours a day.
Our staff turnover is low, and our senior leadership has been part of the AMI family for many years. 2017 brought the addition of Charles Richardson, MD, MBA as partner. His emphasis includes device and software development and implementation, after 20 years in development of software products, services and implantable devices including but not limited to LVADs and the Total Artificial Heart.
AMI Cardiac Monitoring is a subsidiary of parent corporation, iCare Clinical Technologies, and a sister corporation of Miami Research, LLC.
Together we are working to advance services and devices to be on the leading edge of cardiac and other implantable monitoring technologies.
2018 brings new devices and new software, and a committed staff to support all aspects of care delivery. For each of our client hospital, clinic and physician practices, we appreciate your loyalty and share your commitment to quality, patient-centered care.